Stay updated on Daratumumab in NKTCL Clinical Trial
Sign up to get notified when there's something new on the Daratumumab in NKTCL Clinical Trial page.

Latest updates to the Daratumumab in NKTCL Clinical Trial page
- Check7 days agoChange DetectedFooter now displays Revision: v3.3.3; HHS Vulnerability Disclosure and Revision: v3.3.2 have been removed.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe page footer now displays Revision: v3.3.2, replacing the previous Revision: v3.3.1.SummaryDifference0.1%

- Check36 days agoChange DetectedPublication notes were updated to indicate automatic filling from PubMed. The revision version information was updated from v3.2.0 to v3.3.1.SummaryDifference0.1%

- Check43 days agoChange DetectedRemoved the government funding lapse notice (informational banner about operating status) from the page; this non-critical banner does not affect the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check57 days agoChange DetectedThe new screenshot reflects minor UI adjustments such as spacing and header alignment, with no changes to the study details, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check87 days agoChange DetectedThe page now shows the new revision v3.2.0 and removes the old v3.0.2. This is an update to the release/version information.SummaryDifference0.1%

Stay in the know with updates to Daratumumab in NKTCL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab in NKTCL Clinical Trial page.